Efficacy of Pamidronate in Breast Cancer with Bone Metastases: A Randomized Double-Blind Placebo Controlled Multicenter Study

作者: R. Hultborn , S. Gundersen , S. Rydén , E. Holmberg , J. Carstensen

DOI: 10.3109/02841869609083974

关键词:

摘要: Symptoms and complications from skeletal metastases in advanced breast cancer constitute a quantitative qualitative challenge the care of these patients, where introduction undue toxicity should be avoided.

参考文章(4)
A H Paterson, T J Powles, J A Kanis, E McCloskey, J Hanson, S Ashley, Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. Journal of Clinical Oncology. ,vol. 11, pp. 59- 65 ,(1993) , 10.1200/JCO.1993.11.1.59
I. Elomaa, C. Blomqvist, P. Gröhn, L. Porkka, A.-L. Kairento, K. Selander, C. Lamberg-Allardt, T. Holmström, Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. The Lancet. ,vol. 321, pp. 146- 149 ,(1983) , 10.1016/S0140-6736(83)92755-1
F.B. Hagemeister, R. Khetan, P. Allen, P. McLaughlin, M.A. Rodriguez, F. Swan, J.E. Romaguera, F. Cabanillas, Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas Annals of Oncology. ,vol. 5, pp. 41- 46 ,(1994) , 10.1093/ANNONC/5.SUPPL_2.S41
A T van Holten-Verzantvoort, H M Kroon, O L Bijvoet, F J Cleton, L V Beex, G Blijham, J Hermans, J P Neijt, S E Papapoulos, H P Sleeboom, Palliative pamidronate treatment in patients with bone metastases from breast cancer. Journal of Clinical Oncology. ,vol. 11, pp. 491- 498 ,(1993) , 10.1200/JCO.1993.11.3.491